CLOTTAFAST Trademark

Trademark Overview

On Wednesday, November 27, 2013, a trademark application was filed for CLOTTAFAST with the United States Patent and Trademark Office. The USPTO has given the CLOTTAFAST trademark a serial number of 79142702. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, November 26, 2023. This trademark is owned by LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES. The CLOTTAFAST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for use in the treatment of inherited and acquired fibrinogen deficit; blood proteins of natural or transgenic, synthetic or semi-synthetic origin for use in the treatment of inherited and acquired fibrinogen deficit
clottafast

General Information

Serial Number79142702
Word MarkCLOTTAFAST
Filing DateWednesday, November 27, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, November 26, 2023
Registration Number4680294
Registration DateTuesday, February 3, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 18, 2014

Trademark Statements

Goods and ServicesPharmaceutical products and preparations for use in the treatment of inherited and acquired fibrinogen deficit; blood proteins of natural or transgenic, synthetic or semi-synthetic origin for use in the treatment of inherited and acquired fibrinogen deficit

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 20, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameLABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameLABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Friday, February 21, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, February 24, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 28, 2014APPLICATION FILING RECEIPT MAILED
Thursday, March 13, 2014ASSIGNED TO EXAMINER
Thursday, March 20, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 20, 2014REFUSAL PROCESSED BY MPU
Wednesday, March 19, 2014NON-FINAL ACTION WRITTEN
Thursday, March 20, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 15, 2014ASSIGNED TO LIE
Thursday, October 16, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 29, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 4, 2014REFUSAL PROCESSED BY IB
Monday, July 21, 2014NEW REPRESENTATIVE AT IB RECEIVED
Thursday, September 18, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 18, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 18, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 29, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 29, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sunday, May 3, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, October 29, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Friday, November 14, 2014NOTIFICATION PROCESSED BY IB
Tuesday, November 18, 2014PUBLISHED FOR OPPOSITION
Tuesday, November 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, January 26, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 3, 2015REGISTERED-PRINCIPAL REGISTER
Friday, March 27, 2015NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 20, 2021CANCELLED SECTION 71
Wednesday, June 3, 2015FINAL DISPOSITION PROCESSED
Wednesday, June 3, 2015FINAL DISPOSITION NOTICE SENT TO IB
Saturday, July 11, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, February 3, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, April 3, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Friday, April 9, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, April 13, 2021CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Wednesday, April 20, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, July 26, 2022GENERIC MADRID TRANSACTION CREATED
Sunday, June 23, 2024DEATH OF INTERNATIONAL REGISTRATION
Sunday, June 23, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, August 22, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, July 26, 2022GENERIC MADRID TRANSACTION SENT TO IB

Related Keywords

clottafast acquired fibrinogen synthetic inherited deficit treatment products semi origin transgenic